LGND

Ligand Pharmaceuticals Inc

May 18 • 04:00PM ET

207.89

-5.32 -2.50 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: HALO EXEL VKTX ALKS MDGL

| Held by: IJR VTI VB IWM VBR VXF SPSM IJT XSMO IWN

Scroll to Statements

Index	RUT	P/E	28.19	EPS (ttm)	7.38	Insider Own	2.57%	Shs Outstand	20.03M	Perf Week	-5.71%
Market Cap	4.17B	Forward P/E	18.63	EPS next Y	11.16	Insider Trans	-7.76%	Shs Float	19.53M	Perf Month	-10.32%
Enterprise Value	3.84B	PEG	1.12	EPS next Q	2.01	Inst Own	104.46%	Short Float	7.45%	Perf Quarter	10.87%
Income	153.56M	P/S	15.18	EPS this Y	11.35%	Inst Trans	-0.13%	Short Ratio	6.50	Perf Half Y	3.29%
Sales	274.48M	P/B	4.18	EPS next Y	23.30%	ROA	12.60%	Short Interest	1.46M	Perf YTD	9.95%
Book/sh	49.79	P/C	5.35	EPS next 5Y	16.58%	ROE	17.13%	52W High	247.38 -15.96%	Perf Year	98.86%
Cash/sh	38.89	P/FCF	33.85	EPS past 3/5Y	- -	ROIC	10.60%	52W Low	98.89 110.22%	Perf 3Y	170.34%
Dividend Est.	-	EV/EBITDA	28.28	Sales past 3/5Y	10.96% 7.54%	Gross Margin	83.42%	Volatility	3.20% 4.48%	Perf 5Y	162.93%
Dividend TTM	-	EV/Sales	13.99	EPS Y/Y TTM	210.12%	Oper. Margin	36.88%	ATR (14)	9.90	Perf 10Y	167.74%
Dividend Ex-Date	Jul 02, 2010	Quick Ratio	20.95	Sales Y/Y TTM	51.24%	Profit Margin	55.95%	RSI (14)	40.45	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	21.28	EPS Q/Q	69.66%	SMA20	-7.56%	Beta	1.21	Target Price	270.67
Payout	0.00%	Debt/Eq	0.45	Sales Q/Q	14.09%	SMA50	-3.58%	Rel Volume	0.63	Prev Close	213.21
Employees	47	LT Debt/Eq	0.45	Earnings	May 07 BMO	SMA200	8.40%	Avg Volume	223.95K	Price	207.89
IPO	Nov 18, 1992	Option/Short	Yes / Yes	EPS/Sales Surpr.	-10.23% -11.88%	Trades		Volume	140,434	Change	-2.50%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)